AxoGen

US · AXGN #2714 by market cap Listed 1970

36.04 -0.27 -0.74%

Live - 5344 symbols - heartbeat 31s ago · 2026-10-08 05:20

Pre-market 36.02 -0.06%

After-hours 36.04 0.00%

Market cap: 2.11B
P/E (TTM): -53.79
P/B: 8.25
EPS: -0.34
Div yield: 0.00%
52W pos: 55%

Reader sentiment Are you bullish or bearish on AXGN?

Anonymous reader poll. Unscientific, not investment advice.

About AxoGen

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Founded: 1977
CEO: Mr. Michael J. Dale
Employees: 622
Headquarters: Alachua, Florida, United States of America
Fiscal year end: 12-31
Website: axogeninc.com

Company profile

Exchange: US
Symbol: AXGN
Market-cap rank: #2714
Listing date: 1970-01-01
Market cap: 2.11B
Float cap: 1.93B
Shares out: 58.67M
Float shares: 53.55M

Sectors & themes

Medical Devices

Browse all sectors & themes

Quote time 2026-10-08 05:20:31 · For reference only, not investment advice and not tailored to your situation.